PMID- 20620944 OWN - NLM STAT- MEDLINE DCOM- 20100812 LR - 20231213 IS - 1097-4180 (Electronic) IS - 1074-7613 (Print) IS - 1074-7613 (Linking) VI - 32 IP - 6 DP - 2010 Jun 25 TI - Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. PG - 803-14 LID - 10.1016/j.immuni.2010.06.007 [doi] AB - Among human natural killer (NK) cell intermediates in secondary lymphoid tissue (SLT), stage 3 CD34(-)CD117(+)CD161(+)CD94(-) immature NK (iNK) cells uniquely express aryl hydrocarbon receptor (AHR) and interleukin-22 (IL-22), supporting a role in mucosal immunity. The mechanisms controlling proliferation and differentiation of these cells are unknown. Here we demonstrate that the IL-1 receptor IL-1R1 was selectively expressed by a subpopulation of iNK cells that localized proximal to IL-1beta-producing conventional dendritic cells (cDCs) within SLT. IL-1R1(hi) iNK cells required continuous exposure to IL-1beta to retain AHR and IL-22 expression, and they proliferate in direct response to cDC-derived IL-15 and IL-1beta. In the absence of IL-1beta, a substantially greater fraction of IL-1R1(hi) iNK cells differentiated to stage 4 NK cells and acquired the ability to kill and secrete IFN-gamma. Thus, cDC-derived IL-1beta preserves and expands IL-1R1(hi)IL-22(+)AHR(+) iNK cells, potentially influencing human mucosal innate immunity during infection. CI - Copyright 2010 Elsevier Inc. All rights reserved. FAU - Hughes, Tiffany AU - Hughes T AD - Integrated Biomedical Graduate Program, The Ohio State University, Columbus, OH 43210, USA. FAU - Becknell, Brian AU - Becknell B FAU - Freud, Aharon G AU - Freud AG FAU - McClory, Susan AU - McClory S FAU - Briercheck, Edward AU - Briercheck E FAU - Yu, Jianhua AU - Yu J FAU - Mao, Charlene AU - Mao C FAU - Giovenzana, Chiara AU - Giovenzana C FAU - Nuovo, Gerard AU - Nuovo G FAU - Wei, Lai AU - Wei L FAU - Zhang, Xiaoli AU - Zhang X FAU - Gavrilin, Mikhail A AU - Gavrilin MA FAU - Wewers, Mark D AU - Wewers MD FAU - Caligiuri, Michael A AU - Caligiuri MA LA - eng GR - CA68458/CA/NCI NIH HHS/United States GR - R01 CA068458/CA/NCI NIH HHS/United States GR - P01 CA095426/CA/NCI NIH HHS/United States GR - P30 CA016058/CA/NCI NIH HHS/United States GR - CA95426/CA/NCI NIH HHS/United States GR - R37 CA068458/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Immunity JT - Immunity JID - 9432918 RN - 0 (Interleukin-1beta) RN - 0 (Interleukins) RN - 0 (Receptors, Interleukin-1) SB - IM CIN - Immunity. 2010 Jun 25;32(6):734-6. PMID: 20620939 MH - Cell Differentiation/*immunology MH - Cell Proliferation MH - Cell Separation MH - Dendritic Cells/immunology/metabolism MH - Flow Cytometry MH - Humans MH - Immunity, Mucosal/immunology MH - Immunohistochemistry MH - Interleukin-1beta/*immunology/metabolism MH - Interleukins/*immunology/metabolism MH - Killer Cells, Natural/*cytology/immunology/metabolism MH - Lymphoid Tissue/cytology/immunology MH - Receptors, Interleukin-1/immunology/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Interleukin-22 PMC - PMC3742307 MID - NIHMS496905 EDAT- 2010/07/14 06:00 MHDA- 2010/08/13 06:00 PMCR- 2013/08/13 CRDT- 2010/07/13 06:00 PHST- 2009/12/17 00:00 [received] PHST- 2010/05/03 00:00 [revised] PHST- 2010/05/20 00:00 [accepted] PHST- 2010/07/13 06:00 [entrez] PHST- 2010/07/14 06:00 [pubmed] PHST- 2010/08/13 06:00 [medline] PHST- 2013/08/13 00:00 [pmc-release] AID - S1074-7613(10)00210-4 [pii] AID - 10.1016/j.immuni.2010.06.007 [doi] PST - ppublish SO - Immunity. 2010 Jun 25;32(6):803-14. doi: 10.1016/j.immuni.2010.06.007.